[1] McConaghy J R, Fosselman D. Hyperhidrosis: management options[J]. Am Fam Physician,2018,97(11):729-734. [2] Brackenrich J, Fagg C. Hyperhidrosis[M]. Treasure Island(FL): StatPearls Publishing,2021. [3] Walling H W. Clinical differentiation of primary from secondary hyperhidrosis[J]. J Am Acad Dermatol,2011,64:690-695. [4] Smarr K L, Keefer A L. Measures of depression and depressive symptoms: Beck Depression Inventory-Ⅱ (BDI-Ⅱ), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9)[J]. Arthritis Care Res (Hoboken), 2011, 63: S454-466. [5] 刘贤臣, 唐茂芹. 匹兹堡睡眠质量指数的信度和效度研究[J]. 中华精神科杂志, 1996, 29(2):103-107. [6] 凌政,沙亮,季建林,等. 综合医院焦虑抑郁量表在内科门诊患者中的应用[J]. 上海精神医学,2010,22(4):204-206,223. [7] Mirkovic S E, Rystedt A, Balling M, et al. Hyperhidrosis substantially reduces quality of life in children: a retrospective study describing symptoms, consequences and treatment with botulinum toxin[J]. Acta Derm Venereol, 2018,98(1):103-107. [8] Lenefsky M, Rice Z P. Hyperhidrosis and its impact on those living with it[J]. Am J Manag Care,2018,24:S491-S495. [9] Li X, Chen R, Tu Y R, et al.Epidermiological survey of primary palmar hyperhidrosis in adolescents[J]. Chin Med J,2007, 120: 2215-2217. [10]Kouris A, Armyra K, Stefanaki C, et al. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series[J]. Pediatr Dermatol,2015,32(2):226-230. [11]Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: therapeutic options[J]. J Am Acad Dermatol,2019,81(3):669-680. [12]Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: etiology and clinical work-up[J]. J Am Acad Dermatol,2019, 81(3):657-666. [13]Rzany B, Bechara F G, Feise K, et al. Update of the S1 guidelines on the definition and treatment of primary hyperhidrosis[J]. J Dtsch Dermatol Ges,2018,16(7):945-952. [14]Shih C J, Wu J J, Lin M T. Autonomic dysfunction in palmar hyperhidrosis[J]. J Auton Nerv Syst,1983,8:33-43. [15]Hu Y, Converse C, Lyons M C, et al. Neural control of sweat secretion: a review[J]. Br J Dermatol,2018,178:1246-1256. [16]Kristensen J K, Vestergaard D G, Swartling C, et al. Association of primary hyperhidrosis with depression and anxiety: a systematic review[J]. Acta Derm Venereol,2020,100(1):adv00044. [17]Hamm H, Naumann M K, Kowalski J W, et al. Primary focal hyperhidrosis: disease characteristics and functional impairment[J]. Dermatology,2006,212:343-353. [18]Bahar R, Zhou P, Liu Y, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH) [J]. J Am Acad Dermatol,2016,75(6):1126-1133. [19]Bragança G M, Lima S O, Pinto Neto A F, et al. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis[J]. An Bras Dermatol,2014,89(2):230-235. [20]Choi K W, Kim Y K, Jeon H J. Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment[J]. Adv Exp Med Biol, 2020,1191:219-235. [21]Yu J, Rawtaer I, Fam J, et al. Sleep correlates of depression and anxiety in an elderly Asian population[J]. Psychogeriatrics,2016,16(3):191-195. |